S-adenosylhomocysteine and the ratio of S-adenosylmethionine to S-adenosylhomocysteine are not related to folate, cobalamin and vitamin B6 concentrations
- 1 January 2003
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 33 (1), 17-25
- https://doi.org/10.1046/j.1365-2362.2003.01104.x
Abstract
Background It is unclear whether homocysteine itself is causal in the pathogenesis of cardiovascular disease. Alternatively or additionally, the association between homocysteine and cardiovascular disease may be because of its metabolic precursor, S‐adenosylhomocysteine, or of the ratio of S‐adenosylmethionine to S‐adenosylhomocysteine. Therefore, it is relevant to know how these moieties are interrelated, and whether, as is the case for homocysteine, they are influenced by blood levels of folate, cobalamin or vitamin B6. Design We cross‐sectionally studied a population‐based cohort of 97 Caucasian subjects aged 60–85 years. Concentrations of homocysteine, S‐adenosylhomocysteine, S‐adenosylmethionine, folate, cobalamin and vitamin B6 were measured in fasting blood samples. Results In multiple regression analysis, homocysteine was associated with vitamin B12 (per 50 pmol L−1 increase of cobalamin, change in homocysteine, –0·70 mmol L−1; 95% CI, −1·30 to −0·10 mmol L−1) and folate (per 100 nmol L−1 increase in erythrocyte folate, change in homocysteine, –0·68 mmol L−1; 95% CI −1·28 to −0·08 mmol L−1). S‐adenosylhomocysteine, S‐adenosylmethionine and the ratio of S‐adenosylmethionine to S‐adenosylhomocysteine were not associated with serum folate, cobalamin or vitamin B6, nor with erythrocyte folate. Furthermore, plasma homocysteine showed a negative correlation with the ratio of S‐adenosylmethionine to S‐adenosylhomocysteine in plasma (r = −0·27; P < 0·01) but not in erythrocytes. Conclusions In contrast to homocysteine, the plasma concentrations of S‐adenosylhomocysteine and the ratio of S‐adenosylmethionine to S‐adenosylhomocysteine were not associated with the folate, cobalamin and vitamin B6 concentrations in the present study. If these precursors in part explain why homocysteine is associated with cardiovascular disease, homocysteine‐lowering treatment with B vitamins may be less effective than currently expected, at least in an elderly population.Keywords
This publication has 37 references indexed in Scilit:
- Homocysteine metabolism in renal failureKidney International, 2001
- Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive diseaseAtherosclerosis, 2001
- Pathways and Regulation of Homocysteine Metabolism in MammalsSeminars in Thrombosis and Hemostasis, 2000
- Consequences of Homocysteine Export and Oxidation in the Vascular SystemSeminars in Thrombosis and Hemostasis, 2000
- Homocysteine and Hypomethylation A Novel Link to Vascular DiseaseTrends in Cardiovascular Medicine, 1999
- Serum Homocysteine and Risk of Coronary Heart Disease and Cerebrovascular Disease in Elderly MenArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?Nephrology Dialysis Transplantation, 1998
- Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremiaKidney International, 1995
- Hyperhomocysteinemia: An Independent Risk Factor for Vascular DiseaseThe New England Journal of Medicine, 1991
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976